BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

982 related articles for article (PubMed ID: 28165223)

  • 1. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
    Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupick√Ĺ D
    ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles.
    Wang H; Zhang C; Zhang Y; Tian R; Cheng G; Pan H; Cui M; Chang J
    J Mater Chem B; 2020 Apr; 8(14):2876-2886. PubMed ID: 32191252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
    Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
    Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy.
    Qu J; Teng D; Sui G; Guan S; Wang Y; Wang Q; Lin Y; Ran H; Wang Z; Wang H
    Biomater Sci; 2020 Jun; 8(11):3116-3129. PubMed ID: 32352102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.
    Dai Y; Wang B; Sun Z; Cheng J; Zhao H; Wu K; Sun P; Shen Q; Li M; Fan Q
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39410-39423. PubMed ID: 31578854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles.
    Huang X; Wu J; He M; Hou X; Wang Y; Cai X; Xin H; Gao F; Chen Y
    Mol Pharm; 2019 May; 16(5):2172-2183. PubMed ID: 30978027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
    Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
    J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel semiconducting nano-agents incorporating tirapazamine for imaging guided synergistic cancer hypoxia activated photo-chemotherapy.
    Zhang G; Wang W; Zou H; Wei Z; Song C; Ran J; Cao Z; Cai Y; Han W
    J Mater Chem B; 2021 Jul; 9(26):5318-5328. PubMed ID: 34231629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
    Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J
    Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation.
    Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L
    Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor.
    Li L; Fu J; Ye J; Liu L; Sun Z; Wang H; Tan S; Zhen M; Wang C; Bai C
    Adv Mater; 2024 Jun; 36(23):e2310875. PubMed ID: 38450765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy.
    Yang Y; Yang X; Li H; Li C; Ding H; Zhang M; Guo Y; Sun M
    Colloids Surf B Biointerfaces; 2019 Jan; 173():564-570. PubMed ID: 30347383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia and Singlet Oxygen Dual-Responsive Micelles for Photodynamic and Chemotherapy Therapy Featured with Enhanced Cellular Uptake and Triggered Cargo Delivery.
    Guo X; Han L; Chen W; He H; Zhang W; Huang C; Wang X
    Int J Nanomedicine; 2024; 19():247-261. PubMed ID: 38229704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronan-fullerene/AIEgen nanogel as CD44-targeted delivery of tirapazamine for synergistic photodynamic-hypoxia activated therapy.
    Hong X; Xu X; Liu Z; Liu S; Yu J; Wu M; Ma Y; Shuai Q
    Nanotechnology; 2021 Aug; 32(46):. PubMed ID: 34325415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized Combination of Photodynamic Therapy and Chemotherapy Using Gelatin Nanoparticles Containing Tirapazamine and Pheophorbide a.
    Lee D; Jang SY; Kwon S; Lee Y; Park E; Koo H
    ACS Appl Mater Interfaces; 2021 Mar; 13(9):10812-10821. PubMed ID: 33624503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered biomimetic nanoreactor for synergistic photodynamic-chemotherapy against hypoxic tumor.
    Guo H; Wang L; Wu W; Guo M; Yang L; Zhang Z; Cao L; Pu F; Huang X; Shao Z
    J Control Release; 2022 Nov; 351():151-163. PubMed ID: 36122895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Paclitaxel Prodrug Activatable by Irradiation in a Hypoxic Microenvironment.
    Zhou S; Hu X; Xia R; Liu S; Pei Q; Chen G; Xie Z; Jing X
    Angew Chem Int Ed Engl; 2020 Dec; 59(51):23198-23205. PubMed ID: 32852145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.
    Guo X; Qu J; Zhu C; Li W; Luo L; Yang J; Yin X; Li Q; Du Y; Chen D; Qiu Y; Lou Y; You J
    Drug Deliv; 2018 Nov; 25(1):585-599. PubMed ID: 29461122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell Membrane-Inspired Polymeric Vesicles for Combined Photothermal and Photodynamic Prostate Cancer Therapy.
    Hu J; Luo H; Qu Q; Liao X; Huang C; Chen J; Cai Z; Bao Y; Chen G; Li B; Cui W
    ACS Appl Mater Interfaces; 2020 Sep; 12(38):42511-42520. PubMed ID: 32897691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light-triggered theranostic liposomes for tumor diagnosis and combined photodynamic and hypoxia-activated prodrug therapy.
    Zhang K; Zhang Y; Meng X; Lu H; Chang H; Dong H; Zhang X
    Biomaterials; 2018 Dec; 185():301-309. PubMed ID: 30265899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.